logo BDSP

Base documentaire


  1. A benefit-cost analysis of two-dose measles immunization in Canada.

    Article - En anglais

    In 1992, because of the limitations of the one-dose measles immunization program, the National Advisory Committee on Immunization (NACl) recommended a two-dose measles immunization program to eliminate measles.

    More recently, NACl recommended also a special catch-up program to prevent predicted measles outbreaks and to achieve an earlier elimitiation of measles.

    The objective of this study was to complete a benefit-cost analysis of a two-dose immunization program with and withou a mass catch-up compaign compared with the current one-dose program.

    The resulting benefit :

    Cost ratios vary between 2.61 : 1 and 4.31 : 1 depending on the strategy used and the age of the children targeted.

    Given the parameters established for this analysing, the benefits of a second-dose vaccination program against measles far outweigh the costs of such a program under all scenarios.

    Mots-clés Pascal : Virus rougeole, Morbillivirus, Paramyxovirinae, Paramyxoviridae, Mononegavirales, Virus, Rougeole, Virose, Infection, Vaccination, Immunisation, Calendrier vaccination, Rappel vaccination, Analyse avantage coût, Analyse économique, Nourrisson, Homme, Enfant, Peau pathologie, Immunoprophylaxie, Canada, Amérique du Nord, Amérique, Economie santé

    Mots-clés Pascal anglais : Measles virus, Morbillivirus, Paramyxovirinae, Paramyxoviridae, Mononegavirales, Virus, Measles, Viral disease, Infection, Vaccination, Immunization, Vaccination schedule, Booster vaccination, Cost benefit analysis, Economic analysis, Infant, Human, Child, Skin disease, Immunoprophylaxis, Canada, North America, America, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0404004

    Code Inist : 002B05C02B. Création : 25/01/1999.